Treatment of Inflammatory Bowel Disease with Biologics (Hardcover, 2018)

1. Mechanism of Action and Pharmacokinetics of Biologics Alan C. Moss 2. Anti-tumor Necrosis Factor Agents in Ulcerative Colitis Kindra Clark-Snustad, Ives Hot, Scott Lee 3. Anti-tumor Necrosis Factor Agents in Crohn's Disease Byron P. Vaughn 4. Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease Sarah Flier 5. Use of Biologics in the Postoperative Management of Crohn's Disease Benjamin H. Click, Miguel Reguiero 6. Biologics in Pregnancy and Breastfeeding Jill K. J. Gaidos, Sunanda V. Kane 7. Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease Parambir S. Dulai, Corey A. Siegel 8. Therapeutic Drug Monitoring of Biologic Agents Frank I. Scott, Mark T. Osterman 9. Use of Biologics in Crohn's Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks Afrin Kamal, Bret Lashner 10. Cessation of Biologics - Can it be Done? Hang Hock Shim, Cynthia H. Seow 11. Biologic Therapy in Pediatric Inflammatory Bowel Disease Sona Patel, Jennifer Strople 12. Infectious Complications of Biologics Renee M. Marchioni Beery, Joshua R. Korzenik 13. Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy Julia Hughes, Millie D. Long 14. Non-infectious and Non-malignant Complications of Biologics Raymond Cross 15. Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances Asher Kornbluth 16. Anti-Integrin Agents in IBD: Efficacy and Risk of Complications Jimmy K. Limdi, Francis A. Farraye 17. Novel Agents in Inflammatory Bowel Disease Fernando Velayos 18. Quality, Safety, and Practical Considerations of Using Biologic Therapies Gil Melmed